The Regulatory Center

Filter Your Results

 

News

 

Edwards Sapien 3 TAVR Device Receives Intermediate-Risk Indication in Europe

September 19, 2016 -- Edwards Lifesciences Corporation announced that it has received CE Mark approval to expand use of the Sapien 3 transcatheter aortic valve replacemen…

Boston Scientific Receives CE Mark Approval for Lotus Edge Valve System

September 19, 2016 -- Boston Scientific Corporation announced European CE Mark approval for the Lotus Edge valve system, the company's next-generation transcatheter aortic…

FDA Approves Bolus Vial Format for Medicure’s Aggrastat

September 1, 2016 -- Medicure Inc. announced that it has received approval from the US Food and Drug Administration (FDA) for its new "bolus vial" product format for…

FDA Approves Expanded Indication for Edwards' Sapien 3 TAVR Device

August 18, 2016 -- Edwards Lifesciences Corporation announced US Food and Drug Administration (FDA) approval to expand use of its Sapien 3 transcatheter aortic valve repl…

CMS Approves LAAO Registry

August 18, 2016 -- The American College of Cardiology (ACC) and the Society for Cardiovascular Angiography and Interventions (SCAI) advised that the LAAO Registry has been ide…

FDA Issues Draft Updated Recommendations on 510(k) Clearance of Device Modifications

August 8, 2016 -- The US Food and Drug Administration (FDA) announced this week that the agency has issued draft updated recommendations on submissions for a new 510(k) c…

Safety Issues Compared for Devices First Approved in Europe Versus the United States

July 25, 2016 -- Medical devices first approved in the European Union are associated with an increased risk of postmarketing safety alerts and recalls compared with …

SCAI and ACC Submit Comments to CMS on Proposed MACRA Structure

July 5, 2016 -- The Society for Cardiovascular Angiography and Interventions (SCAI) and the American College of Cardiology (ACC) have separately submitted comments to the US C…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.